UBS Group’s Global X MSCI China Health Care ETF CHIH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-393
Closed -$5.44K 10379
2023
Q4
$5.44K Buy
393
+293
+293% +$4.12K ﹤0.01% 7787
2023
Q3
$1.37K Buy
+100
New +$1.39K ﹤0.01% 7965
2023
Q2
Sell
-5
Closed -$80 10040
2023
Q1
$80 Sell
5
-372
-99% -$6.49K ﹤0.01% 9275
2022
Q4
$6.24K Buy
377
+215
+133% +$3.25K ﹤0.01% 9061
2022
Q3
$2K Sell
162
-1,300
-89% -$20.7K ﹤0.01% 9830
2022
Q2
$26K Buy
1,462
+442
+43% +$6.9K ﹤0.01% 6575
2022
Q1
$18K Buy
1,020
+89
+10% +$1.65K ﹤0.01% 7601
2021
Q4
$20K Buy
+931
New +$22.2K ﹤0.01% 7865
2021
Q2
Sell
-1,738
Closed -$48K 9982
2021
Q1
$48K Buy
+1,738
New +$50.2K ﹤0.01% 6601
2020
Q4
Sell
-5
Closed 8893
2020
Q3
$0 Buy
+5
New +$122 ﹤0.01% 8532
2020
Q2
Sell
-847
Closed -$14K 8478
2020
Q1
$14K Sell
847
-807
-49% -$14.7K ﹤0.01% 6744
2019
Q4
$29K Sell
1,654
-196
-11% -$3.37K ﹤0.01% 6669
2019
Q3
$29K Buy
1,850
+623
+51% +$9.95K ﹤0.01% 6515
2019
Q2
$19K Buy
+1,227
New +$20K ﹤0.01% 6661

UBS Group's CHIH Position: Q1 2024 in Review

UBS Group sold out of Global X MSCI China Health Care ETF (CHIH) in Q1 2024, closing a stake of 393 shares — an estimated $5.44K sold.

UBS Group first reported a position in CHIH in Q2 2019 and held it in 14 quarters. The position peaked at $48K in Q1 2021. 0 funds tracked by Wall St. Rank hold CHIH as of Q1 2024.

  • UBS Group reported no remaining Global X MSCI China Health Care ETF position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 393 Global X MSCI China Health Care ETF shares in Q1 2024, an estimated $5.44K.
  • UBS Group first reported a position in Global X MSCI China Health Care ETF in Q2 2019 and held it in 14 quarters.
  • UBS Group's Global X MSCI China Health Care ETF position peaked at $48K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Global X MSCI China Health Care ETF as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.